Cognition Therapeutics Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cognition Therapeutics Inc's ROI in the second quarter of 2026?
Cognition Therapeutics Inc recorded a cumulative net loss of $-17 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -49.8%.

Within the Healthcare sector Cognition Therapeutics inc achieved the highest return on investment. While the total ranking for ROI remained the same, compared to the first quarter of 2026 at no. .

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	150.57 %	55.15 %	4.9 %	-18.37 %	-50.36 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	33	30	34	37	7
Return On Investment (TTM)	-49.8 %	-72.14 %	-103.22 %	-147.99 %	-245.42 %
CGTX's Overall Ranking	#	#	#	#	#
Seq. Investment Change TTM	24.12 %	19.27 %	20.32 %	40.66 %	-23.14 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-17	-20	-23	-28	-33

CGTX Company Profile >> Back to CGTX Roi Comparisons >> See Annual CGTX Return On Investment

Return On Investment CGTX's Ranking
Within:	No.
Industry	#
Sector	#
Overall	#

Return On Investment Statistics
High	Average	Low
0 %	0 %	0 %

Financial Statements
Cognition Therapeutics Inc's II. Quarter Investments	$ 33 Millions	CGTX's Balance sheet
Cognition Therapeutics Inc's II. Quarter Income	$ -4 Millions	Quarterly CGTX's Income Statement
CGTX's Income by Division		See CGTX's Income by Division

CGTX Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	34	19	25	43	51
Y / Y Investment Growth	80.53 %	-23.61 %	-41.37 %	-16.86 %	-
Net Income in Millions	-23	-34	-26	-21	-12
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-68.15 %	-177.93 %	-103.18 %	-50.19 %	-22.85 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Biotechnology & Pharmaceuticals Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CGTX's Roi Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CGTX's Competitors
Subscribers only: Roi for Cognition Therapeutics Inc's Suppliers
Subscribers only: Return On Investment for CGTX's Customers

Other Ratios
CGTX's Roa	CGTX's Inventory Turnover Ratio	CGTX's Growth Rates	CGTX's Dividend Statistics
	CGTX's Profitability Ratios	CGTX's Asset Turnover Ratio	CGTX's Dividend Growth
CGTX's Roe	CGTX's Valuation Ratios	CGTX's Financial Strength Ratios	CGTX's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-08T17:05:34+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.